Filing excerpt
On February 11, 2026, Bio-Techne Corporation (the “Company”) announced that Dr. Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment, will be transitioning from his role, effective March 1, 2026...
The appointment of a new segment president, following the 'without cause' termination of his predecessor, signals a potential strategic shift or performance review within the key Diagnostics and Spatial Biology division.
Filing excerpt
On February 11, 2026, Bio-Techne Corporation (the “Company”) announced that Dr. Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment, will be transitioning from his role, effective March 1, 2026...
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Competitors
sec-8ksuccessionAnnouncementGet every 8-K signal for Bio-Techne and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/995ef64b-f0a3-439c-9b8f-1de95ca28aba returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.
{
"signal_id": "995ef64b-f0a3-439c-9b8f-1de95ca28aba",
"signal_type": "sec-8k",
"signal_subtype": "successionAnnouncement",
"detected_at": "2026-02-17T09:04:08.072+00:00",
"company": {
"name": "Bio-Techne",
"domain": "bio-techne.com"
},
"data": {
"detail": "The appointment of a new segment president, following the 'without cause' termination of his predecessor, signals a potential strategic shift or performance review within the key Diagnostics and Spatial Biology division. The new leader, with a mandate for growth and innovation, will likely re-evaluate current projects, budgets, and vendor partnerships, creating a window of opportunity for new solution providers.",
"metrics": {
"pct": 0.75,
"timeframe": "next_quarter",
"pct_context": "Target annual cash incentive bonus as a percentage of base salary",
"dollar_context": "New Segment President's annual base salary",
"dollar_millions": 0.505
},
"summary": "Bio-Techne names Steve Crouse President of Diagnostics & Spatial Biology, replacing Dr. Matt McManus effective March 1, 2026.",
"excerpts": "On February 11, 2026, Bio-Techne Corporation (the “Company”) announced that Dr. Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment, will be transitioning from his role, effective March 1, 2026...",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/842023/000110465926013412/tech-20260209x8k.htm",
"filing_date": "2026-02-11",
"filing_year": 2026,
"sales_relevance": "Upcoming vendor review window",
"signal_category": "leadership",
"competitors_mentioned": [
"Thermo Fisher Scientific"
],
"technologies_mentioned": [
"Spatial Biology",
"protein analysis",
"immunoassays"
]
}
}
curl https://signals.autobound.ai/v1/signals/995ef64b-f0a3-439c-9b8f-1de95ca28aba \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bio-techne.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.